Table 1.
Case No. | Age/sex | Histological type* | Invasion** | LN** | Stage ** | CGH | p53 IHC | TP53 mutation |
---|---|---|---|---|---|---|---|---|
M1 | 57/M | tub1 | T1(M) | N0 | IA | c/a | + | NT |
M2 | 72/M | tub1 | T1(M) | N0 | IA | c/a | + | NT |
M3 | 67/F | tub1 | T1(M) | N0 | IA | c/a | - | - |
M4 | 67/M | tub1 | T1(M) | N0 | IA | c/a | - | - |
M5 | 74/M | tub1 | T1(M) | N0 | IA | c/a | + | - |
M6 | 65/M | tub1 | T1(M) | N0 | IA | c/a | + | - |
M7 | 67/F | tub1 | T1(M) | N0 | IA | c/a | + | - |
M8 | 70/F | tub1 > pap | T1(M) | N0 | IA | c/a | - | - |
M9 | 51/M | tub1 > tub2 | T1(M) | N0 | IA | c/a | + | - |
M10 | 52/M | tub2 | T1(M) | N0 | IA | c/a | + | - |
M11 | 57/F | tub2 | T1(M) | N0 | IA | NT/a | - | - |
M12 | 89/M | tub2 | T1(M) | N0 | IA | NT/a | + | + |
M13 | 70/M | tub1 | T1(M) | N0 | IA | NT/a | - | NA |
S1m | 73/F | tub2 | T1(SM) | N0 | IA | c/a | + | - |
S1i | NT/a | + | - | |||||
S2m | 81/F | pap | T1(SM) | N1 | IB | c/a | + | - |
S2i | NT/a | + | + | |||||
S3m | 79/M | tub1 | T1(SM) | N0 | IA | c/a | + | + |
S3i | NT/a | + | + | |||||
S4m | 63/M | tub2 > tub1 | T1(SM) | N0 | IA | c/NT | + | NT |
S5m | 75/M | pap > tub2 | T1(SM) | N1 | IB | c/NT | + | NT |
S6m | 79/M | pap | T1(SM) | N1 | IB | c/NT | + | NT |
A1m | 71/M | tub2 | T2(SS) | N2 | IIIA | c/a | null | - |
A1i | NT/a | null | NA | |||||
A2m | 73/M | tub1 > tub2 | T2(SS) | N0 | IB | c/a | + | - |
A2i | NT/a | + | + | |||||
A3m | 56/M | pap | T2(SS) | N1 | II | c/a | + | - |
A3i | NT/a | + | + | |||||
A4m | 81/M | tub2/pap | T2(SS) | N2 | IIIA | c/a | null | - |
A4i | NT/a | null | + | |||||
A5m | 56/M | tub1 | T2(MP) | N0 | IB | c/NT | - | NT |
A5i | NT/NA | - | NA | |||||
A6m | 45/F | tub2 | T2(SS) | N1 | IB | c/NT | + | NT |
A7m | 79/F | tub2 | T2(MP) | N1 | IB | c/NT | +/- | NT |
A8m | 69/M | tub1 | T3(SE) | N2 | IIIB | c/a | null | - |
A8i | NT/a | null | NA | |||||
A9m | 67/F | tub2 | T2(SS) | N1 | II | c/a | + | - |
A9i | NT/a | + | + |
* Japanese classification of gastric carcinoma; ** pTNM classification. In the column of Case No, M = intramucosal cancer; S = cancer involving the submucosa; A = advanced cancer; m = mucosal part; i = invasive part. In the column of CGH, c = chromosomal CGH; a = array CGH. In the column of p53 immunohistochemistry (IHC); "+" indicates diffusely (>70%) positive nuclei, "-" indicates sporadically (<5%) positive nuclei; "null" indicates no immunoreactivity at all. In the column of TP53 mutation; "+" and "-" indicate presence and absence of mutation, respectively; NA = not assessable; NT = not tested.